The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity
Open accessAbstract
A model of Leishmania major infection in C57BL/6 mice has been established that combines two main features of natural transmission: low dose (100 metacyclic promastigotes) and inoculation into a dermal site (the ear dermis). The evolution of the dermal lesion could be dissociated into two distinct phases. The initial “silent” phase, lasting 4–5 wk, favored establishment of the peak load of parasites in the dermis in the absence of lesion formation or any overt histopathologic changes in the site. The second phase corresponds to the development of a lesion associated with an acute infiltration of neutrophils, macrophages, and eosinophils into the dermis and was coincident with the killing of parasites in the site. The onset of immunity/pathology was correlated with the appearance of cells staining for IL-12p40 and IFN-γ in the epidermal compartment, and an expansion of T cells capable of producing IFN-γ in the draining lymph node. Parasite growth was not enhanced over the first 4.5 wk in anti-CD4-treated mice, SCID mice, or C57BL/6 mice deficient in IL-12p40, IFN-γ, CD40 ligand, or inducible NO synthase. These mice all failed to ultimately control infection in the site, but in some cases (anti-CD4 treated, IL-12p40−/−, CD40 ligand−/−, and SCID) high dermal parasite loads were associated with little or no pathology. These results extend to a natural infection model a role for Th1 cells in both acquired resistance and lesion formation, and document the remarkable avoidance of this response during a prolonged phase of parasite amplification in the skin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recombinant interleukin 12 cures mice infected with Leishmania major.
Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., & Gately, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1505 · Cited by 761
Sypek, J. P., Chung, C. L., Mayor, S. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., & Schaub, R. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1797 · Cited by 720
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice
TITUS, R. G., MARCHAND, M., BOON, T., & LOUIS, J. A. (1985) · Parasite Immunology · doi:10.1111/j.1365-3024.1985.tb00098.x · Cited by 514
Belkaid, Y., Kamhawi, S., Modi, G., Valenzuela, J., Noben-Trauth, N., Rowton, E., Ribeiro, J., & Sacks, D. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1941 · Cited by 407
Self-citationIL-4 induces a Th2 response in Leishmania major-infected mice
Chatelain, R., Varkila, K., & Coffman, R. L. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1182 · Cited by 397
Belosevic, M., Finbloom, D. S., Van Der Meide, P. H., Slayter, M. V., & Nacy, C. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.1.266 · Cited by 370
Diefenbach, A., Schindler, H., Donhauser, N., Lorenz, E., Laskay, T., MacMicking, J., Röllinghoff, M., Gresser, I., & Bogdan, C. (1998) · Immunity · doi:10.1016/s1074-7613(00)80460-4 · Cited by 368
Reiner, S. L., Zheng, S., Wang, Z. E., Stowring, L., & Locksley, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.447 · Cited by 363
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., & Bogdan, C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1501 · Cited by 331
CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major
Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G., & Maliszewski, C. R. (1996) · Immunity · doi:10.1016/s1074-7613(00)80436-7 · Cited by 321
Cited by
Murray, H. W., Berman, J. D., Davies, C. R., & Saravia, N. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67629-5 · Cited by 1,771
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M., & Sacks, D. L. (2002) · Nature · doi:10.1038/nature01152 · Cited by 1,725
Self-citationMultifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., De Luca, P. M., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,378
The immunology of susceptibility and resistance to Leishmania major in mice
Sacks, D., & Noben-Trauth, N. (2002) · Nature Reviews Immunology · doi:10.1038/nri933 · Cited by 1,208
Self-citationCompartmentalized Control of Skin Immunity by Resident Commensals
Naik, S., Bouladoux, N., Wilhelm, C., Molloy, M. J., Salcedo, R., Kastenmuller, W., Deming, C., Quinones, M., Koo, L., Conlan, S., et al. (2012) · Science · doi:10.1126/science.1225152 · Cited by 1,092
Self-citationNatural regulatory T cells in infectious disease
Belkaid, Y., & Rouse, B. T. (2005) · Nature Immunology · doi:10.1038/ni1181 · Cited by 1,035
Self-citationIn Vivo Imaging Reveals an Essential Role for Neutrophils in Leishmaniasis Transmitted by Sand Flies
Peters, N. C., Egen, J. G., Secundino, N., Debrabant, A., Kimblin, N., Kamhawi, S., Lawyer, P., Fay, M. P., Germain, R. N., & Sacks, D. (2008) · Science · doi:10.1126/science.1159194 · Cited by 834
Self-citationLeón, B., López-Bravo, M., & Ardavín, C. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.017 · Cited by 704
Cutaneous leishmaniasis: Immune responses in protection and pathogenesis
Scott, P., & Novais, F. O. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.72 · Cited by 591
Anderson, C. F., Oukka, M., Kuchroo, V. J., & Sacks, D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061886 · Cited by 571
Self-citationBelkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., & Sacks, D. L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1497 · Cited by 557
“major persistence and reactivation after clinical cure have been examined in a model of latency established either as a consequence of natural sand fly challenge or an infection model that combines two main aspects of natural challenge, low parasite dose (100 metacyclic promastigotes) and inoculation into skin (ear de…”
Self-citationChackerian, A. A., Alt, J. M., Perera, T. V., Dascher, C. C., & Behar, S. M. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4501-4509.2002 · Cited by 407
Inflammasome-derived IL-1β production induces nitric oxide–mediated resistance to Leishmania
Lima-Junior, D. S., Costa, D. L., Carregaro, V., Cunha, L. D., Silva, A. L. N., Mineo, T. W. P., Gutierrez, F. R. S., Bellio, M., Bortoluci, K. R., Flavell, R. A., et al. (2013) · Nature Medicine · doi:10.1038/nm.3221 · Cited by 360
Protection Against Cutaneous Leishmaniasis Resulting from Bites of Uninfected Sand Flies
Kamhawi, S., Belkaid, Y., Modi, G., Rowton, E., & Sacks, D. (2000) · Science · doi:10.1126/science.290.5495.1351 · Cited by 347
Self-citationBelkaid, Y., Von Stebut, E., Mendez, S., Lira, R., Caler, E., Bertholet, S., Udey, M. C., & Sacks, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3992 · Cited by 311
Self-citationMendez, S., Reckling, S. K., Piccirillo, C. A., Sacks, D., & Belkaid, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040298 · Cited by 296
Self-citationMcMahon‐Pratt, D., & Alexander, J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00190.x · Cited by 283
Immunopathogenesis of infection with the visceralizing Leishmania species
Wilson, M. E., Jeronimo, S. M. B., & Pearson, R. D. (2005) · Microbial Pathogenesis · doi:10.1016/j.micpath.2004.11.002 · Cited by 281
Aga, E., Katschinski, D. M., van Zandbergen, G., Laufs, H., Hansen, B., Müller, K., Solbach, W., & Laskay, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.898 · Cited by 280
Mechanisms of Immune Evasion in Leishmaniasis
Gupta, G., Oghumu, S., & Satoskar, A. R. (2013) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-407679-2.00005-3 · Cited by 259
Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252
Persistence Without Pathology in Phosphoglycan-Deficient Leishmania major
Späth, G. F., Lye, L.-F., Segawa, H., Sacks, D. L., Turco, S. J., & Beverley, S. M. (2003) · Science · doi:10.1126/science.1087499 · Cited by 167
Self-citationThe impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis
Peters, N. C., & Sacks, D. L. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01348.x · Cited by 118
Self-citationSkin mast cells control T cell‐dependent host defense in Leishmania major infections
Maurer, M., Lopez Kostka, S., Siebenhaar, F., Moelle, K., Metz, M., Knop, J., & von Stebut, E. (2006) · The FASEB Journal · doi:10.1096/fj.06-5860com · Cited by 115
CD4 + T Cells: Guardians of the Phagosome
Tubo, N. J., & Jenkins, M. K. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00097-13 · Cited by 105
Suppression of LPS-induced inflammatory responses in macrophages infected with Leishmania
Lapara, N. J., & Kelly, B. L. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-8 · Cited by 68
Venugopal, G., Bird, J. T., Washam, C. L., Roys, H., Bowlin, A., Byrum, S. D., & Weinkopff, T. (2022) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0010518 · Cited by 26
Metadata
- Authors
- Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G., & Sacks, D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-07
- Volume
- 165
- Issue
- 2
- Pages
- 969-977
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2110078092
- Cited by
- 363
- References
- 41
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.